August 24, 2024
1 min watch
Save
VIDEO: Bioavailability of Vevye allows for faster results in dry eye disease
Issue: September 25, 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Analisa Arosemena, MD, of CorrectVision Laser Institute discusses Vevye for the treatment of dry eye disease.
Vevye (cyclosporine ophthalmic solution 0.1%, Harrow) features a water-free semifluorinated alkane vehicle, which improves the bioavailability of the cyclosporine and allows for faster results, according to Arosemena.
“As a user, I can tell you that it’s also very comfortable,” she said. “Ninety-eight percent actually say that they do not feel the stinging that we can feel with some of the other water-soluble cyclosporines.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Arosemena reports consulting for Harrow.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.